Oscar Health, Inc. (OSCR) Q3 2025 10-Q Quarterly Report
Oscar Health, Inc. (OSCR) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Oscar Health, Inc. Q3 2025 10-Q Analysis
Management Discussion & Analysis
- • Revenue not specified, no YoY comparison provided in the text
- • Net investment income $53.2M for Q3 2025 vs $50.3M Q3 2024, $153.3M for 9M 2025 vs $143.3M 9M 2024
Risk Factors
- • New risk from CMS Program Integrity Rules enacted June 25, 2025, causing stricter APTC eligibility verification and shortening open enrollment impacting membership
- • Increased estimate of risk adjustment transfer as of Sept 30, 2025 reflects worsening market morbidity, raising potential capital contribution needs and liquidity pressures
Oscar Health, Inc. Q3 2025 Quarterly FinancialsXBRL
Revenue
$9M
▲ +79.6% YoY▲ +35.5% QoQ
Net Income
-$137M
▼ -151.8% YoY▲ +39.8% QoQ
Operating Margin
-1468.6%
▼ -48116bp YoY▲ +207895bp QoQ
Net Margin
-1561.8%
▼ -44732bp YoY▲ +195311bp QoQ
ROE
-13.4%
Total Assets
$5.7B
EPS (Diluted)
$-0.52
▼ -205.9% YoY▲ +30.7% QoQ
Operating Cash Flow
-$965M
▼ -92.9% YoY▼ -289.5% QoQ
Source: XBRL data from Oscar Health, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Oscar Health, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.